Published by
Bo Wang, Xiang-Jin Meng Hepatitis E virus (HEV) is distinct from other hepatotropic viruses in that it is zoonotic and can infect across species barriers. HEV-1 and HEV-2 exclusively infect humans, whereas HEV-3 and HEV-4 ar...
Published by
Xiang-Jin Meng Postdoctoral Associate Position in Molecular Virology
The Meng lab at Virginia Tech [http://www.tinyurl.com/meng-lab] is seeking a postdoctoral associate in molecular virology. The candidate is exp...
Published by
Susanne Dudman, Asma Aziz We conducted a large phase 4, double-blind, cluster-randomised trial in 67 villages in Matlab, Bangladesh, and hereby share some of our results. Between 2017 and2021, 19 460 participants were randomis...
Published by
Sebastien Lhomme Virus–host recombinant variants (VHRVs) were described in immunocompromised patients infected with genotype 3 HEV strains. These variants have the insertion of human gene fragments in the polyprolin...
Published by
Siddharth Sridhar, JIANWEN SITU Human cases of Rocahepevirus ratti (HEV-C1) infection are increasingly reported worldwide. Serological tests for HEV-C1 infection are necessary for measuring the clinical burden of HEV-C1 on communiti...
Published by
Morgan Herod Hepatitis E virus (HEV) is a common cause of acute viral hepatitis (inflammation of the liver). Although the infection usually self-resolves in healthy people, occasionally it can lead to acute liver ...
Published by
Qiang Ding, Xiaohui Ju Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world. There are no direct-acting antivirals for HEV treatment. The mechanism of HEV replication, especially host facto...
Published by
Zongdi Feng, Arash Grakoui HEV has a single capsid protein encoded by its open reading frame (ORF) 2. Recent studies have shown that most of the ORF2 protein found in the circulation of HEV-infected patients is not associated w...
Published by
Bo Wang, Xiang-Jin Meng Hepatitis E virus (HEV) causes chronic hepatitis E that requires antiviral therapy in immunosuppressed individuals. Ribavirin (RBV) is the main therapeutic option for chronic hepatitis E as an off-lab...
Published by
Thibault Tubiana, Sonia FIEULAINE, Stéphane Bressanelli Structural biology, the field that produces atomic-level structures of biomacromolecules, has undergone several revolutions in the last ten years. The latest, and possibly the most far-reaching, is th...
GHEP offers free membership for your better connection with the hepatitis E community
EVENTS
2025-01-18
International Joint Meeting on Viral Infections of the Liver and the Heart (2025) Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding.
Venue:
Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany.
Organisers:
Prof. Dr. Jens Kurreck,
Dr. rer. nat. Daniel Todt,
Prof. Dr. med. Heiner Wedemeyer,
More information:Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)